首页 | 本学科首页   官方微博 | 高级检索  
检索        

莫西沙星与左氧氟沙星对耐多药肺结核病的治疗效果
引用本文:张向丛,李新霞,王淑平,张笑丹,蔡兰英,邵艳欣,白云,张俊萍,高官聚.莫西沙星与左氧氟沙星对耐多药肺结核病的治疗效果[J].河北医药,2007,29(6):557-558.
作者姓名:张向丛  李新霞  王淑平  张笑丹  蔡兰英  邵艳欣  白云  张俊萍  高官聚
作者单位:050041,石家庄市,河北省胸科医院结核内科
摘    要:目的 评价新一代氟喹诺酮类药物莫西沙星对耐多药肺结核病(MDR-PTB)的治疗作用.方法 132例 MDR-PTB患者随机分为2组:治疗组(Ⅰ组)用莫西沙星0.4 g,每日1次;对照组(Ⅱ组)用左氧氟沙星0.4 g,每日1次,疗程12月,同时辅以其他抗痨药物治疗,126例完成疗程.结果 治疗组痰菌阴转率明显高于对照组(P<0.05),影像吸收率、副作用2组间差异无显著性(P>0.05).结论 莫西沙星是一种安全、有效的抗MDR-PTB药物.

关 键 词:莫西沙星  左氧氟沙星  耐多药肺结核病  临床疗效
修稿时间:2007-01-19

The therapeutic effect of moxifloxacin and levofloxacin on multiple drug resistant pulmonary tuberculosis
ZHANG Xiangcong, LI Xinxia, WANG Shuping,et al..The therapeutic effect of moxifloxacin and levofloxacin on multiple drug resistant pulmonary tuberculosis[J].Hebei Medical Journal,2007,29(6):557-558.
Authors:ZHANG Xiangcong  LI Xinxia  WANG Shuping  
Institution:Hebei Provincial Thoracic Hospital, Shijiazhuang 050041
Abstract:Objective To evaluate the therapeutic effect ofmoxifloxacin and levofloxacin on multiple drug resistant pulmonary tuberculosis(MDR-PTB).Methods 132 patients with MDR-PTB were randomly divided into two groups.The trial group was treated with moxifloxacin 0.4g once a day,while the control group was treated with levofloxacin 0.4g once a day,with a treatment course of 12 months,at the same time the other anti-tuberculosis drugs were also used for both groups.126 patients finished the treatment course.Results The sputum negative conversion rate in trial group was significantly higher than those in control group(P<0.05).There were no significant differences in imaginga bsorption rate and side effects between two groups(P>0.05).Conclusion Moxifloxacin is an effective drug in treating MDR-PTB.
Keywords:moxifloxacin  levofloxacin  multiple drug resistant pulmonary tuberculosis  clinical efficacy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号